Stephen David Prior, Chief Strategy Officer at AN2 Therapeutics, Inc. (ANTX), sold 765 shares at $1.14 ($872) on 2025-11-04, disclosed to the SEC on 2025-11-06.
Open-market sale of $872 ANTX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |